Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Thomas C. Blevins"'
Autor:
Gregory W. Randolph, Julie Ann Sosa, Yangyang Hao, Trevor E. Angell, David C. Shonka, Virginia A. LiVolsi, Paul W. Ladenson, Thomas C. Blevins, Quan-Yang Duh, Ronald Ghossein, Mack Harrell, Kepal Narendra Patel, Michael H. Shanik, S. Thomas Traweek, P. Sean Walsh, Michael W. Yeh, Amr H. Abdelhamid Ahmed, Allen S. Ho, Richard J. Wong, Joshua P. Klopper, Jing Huang, Giulia C. Kennedy, Richard T. Kloos, Peter M. Sadow
Publikováno v:
Thyroid : official journal of the American Thyroid Association, vol 32, iss 9
Background: Cytopathological evaluation of thyroid fine-needle aspiration biopsy (FNAB) specimens can fail to raise preoperative suspicion of medullary thyroid carcinoma (MTC). The Afirma RNA-sequencing MTC classifier identifies MTC among FNA samples
Autor:
Thomas C, Blevins, Yaron, Raiter, Bin, Sun, Charles, Donnelly, Roxann, Shapiro, Anoop, Chullikana, Anita, Rao, Laxmikant, Vashishta, Gopinath, Ranganna, Abhijit, Barve
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 36(6)
MYL-1601D is a proposed biosimilar of originator insulin aspart, NovologThis study assessed the immunogenicity, efficacy, and safety of MYL-1601D with Ref-InsAsp-US in patients with type 1 diabetes mellitus (T1D).This was a 24-week, open-label, rando
Autor:
Thomas C Blevins, Azeez Farooki
Publikováno v:
Postgraduate Medicine. 129:159-168
Canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor approved for the treatment of type 2 diabetes mellitus (T2DM), lowers blood glucose by inhibiting renal glucose reabsorption and increasing urinary glucose excretion. It has been repo
Autor:
Caitlin Rush, Thomas J. Starc, Robert A. Hegele, Alan S. Brown, Margaret R. Diffenderfer, Sarah Kozmic, Ashley Deleigh Davila, Lisa C. Hudgins, Thomas C. Blevins, Ernst J. Schaefer, Vadzim Chyzhyk, Andrew S. Geller, Lihong He
Publikováno v:
Journal of clinical lipidology. 13(1)
Triglyceride (TG) concentrations2000 mg/dL are extremely elevated and increase the risk of pancreatitis.We characterized five cases and two kindreds and ascertained prevalence in a reference laboratory population.Plasma lipids and DNA sequences of LP
Publikováno v:
The Journal of family practice. 66
Sponsors of follow-on biologics can submit their applications for approval by the US Food and Drug Administration (FDA) under 2 distinct pathways. The submission pathway is determined by the pathway previously used by the reference biologic product,
Autor:
Ernst J. Schaefer, Margaret R. Diffenderfer, Thomas C. Blevins, Ashley Deleigh Davila, Robert A. Hegele
Publikováno v:
Journal of Clinical Lipidology. 12:555
Autor:
Thomas C. Blevins
Publikováno v:
Journal of Diabetes Science and Technology. 4:440-456
Professional continuous glucose monitoring (PCGM) is a 3–5 day test done to evaluate diabetes control. The PCGM test uses interstitial glucose measurements done every 5 min with a glucose-oxidase-impregnated membrane. The PCGM test evaluates glucos
Autor:
Thomas C, Blevins, Bruce W, Bode, Satish K, Garg, George, Grunberger, Irl B, Hirsch, Lois, Jovanovič, Elizabeth, Nardacci, Eric A, Orzeck, Victor L, Roberts, William V, Tamborlane, Caitlin, Rothermel
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 16(5)
Definitions Personal CGM Personal CGM devices are owned by patients. With personal real-time CGM, glucose values are visible continuously; this allows for immediate therapeutic adjustments based on “real-time” glucose results. Professional CGM CG
Autor:
Thomas C Blevins
Publikováno v:
Postgraduate medicine. 122(1)
Type 2 diabetes mellitus and comorbidities related to overweight/obesity are risk factors for the development of cardiovascular disease (CVD). In addition to insulin resistance and progressive beta-cell failure as key factors in the pathogenesis of t